drugset
drugset / Trial / NCT04194086

Population Pharmacokinetics and Safety of Oral Posaconazole in Children With Leukemia

NCT04194086 ↗

Phase 1/2 Completed 42 enrolled Zhujiang Hospital Guangdong Provincial People's Hospital · collab
NaSingle-groupOpen-labelTreatment

Summary

This study is designed to evaluate the safety, efficacy and Population Pharmacokinetics of Oral Posaconazole in Children with leukemia.

Timeline

Start
2018-11-01
Primary completion
2021-07-01
Completion
2021-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Posaconazole Small molecule 5 mg/kg Oral

Indications

acute leukemia